Literature DB >> 19299807

Bacterial colonization after tunneling in 402 perineural catheters: a prospective study.

Vincent Compère1, J F Legrand, P G Guitard, K Azougagh, O Baert, A Ouennich, V Fourdrinier, N Frebourg, B Dureuil.   

Abstract

BACKGROUND: Bacterial colonization of peripheral nerve catheters is frequent, although infection is relatively rare. With central venous catheters, the tunneling of the catheter into the subcutaneous tissue significantly decreases catheter colonization and catheter-related sepsis. We evaluated the incidence of bacterial colonization in adult patients with tunnelized perineural nerve catheters.
METHODS: Peripheral nerve catheters placed under sterile conditions for postoperative analgesia were evaluated prospectively. After removal, they were analyzed for colonization. Quantitative culture was used as described by Brun-Buisson for intravascular catheters. The site of insertion was monitored daily for any signs of infection.
RESULTS: Four-hundred-two patients were included in the study during a 2-yr period. The mean duration of peripheral nerve catheters was 48 h (47-50.4). Positive culture occurred in 25 catheters, indicating that the incidence of colonization was 6.22% (3.8-8.5). The microbiological analysis of the catheter tip cultures revealed coagulase-negative staphylococci in 72%. Twenty-two catheters of 25 catheters each had one microorganism, and for three catheters, two microorganisms were identified. No infection was found in any patient.
CONCLUSION: The incidence of perineural catheter colonization is low with subcutaneous tunneling. Controlled randomized studies are warranted to determine whether this procedure decreases the risk for infection.

Entities:  

Mesh:

Year:  2009        PMID: 19299807     DOI: 10.1213/ane.0b013e31819673aa

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  8 in total

Review 1.  [Complications of peripheral regional anesthesia].

Authors:  M Neuburger; J Büttner
Journal:  Anaesthesist       Date:  2011-11       Impact factor: 1.041

2.  [Sheared catheter in regional anaesthesia : causes and follow-up of an axiallary plexus catheter].

Authors:  F Reisig; J Breitbarth; B Ott; J Büttner
Journal:  Anaesthesist       Date:  2011-09-01       Impact factor: 1.041

3.  Long-term use of nerve block catheters in paediatric patients with cancer related pathologic fractures.

Authors:  L L Burgoyne; L A Pereiras; L A Bertani; R N Kaddoum; M Neel; L G Faughnan; D L Anghelescu
Journal:  Anaesth Intensive Care       Date:  2012-07       Impact factor: 1.669

4.  Continuous tunnelled femoral nerve block for palliative care of a patient with metastatic osteosarcoma.

Authors:  H L Pacenta; R N Kaddoum; L A Pereiras; E J Chidiac; L L Burgoyne
Journal:  Anaesth Intensive Care       Date:  2010-05       Impact factor: 1.669

5.  Risk of catheter-associated infection in young hematology/oncology patients receiving long-term peripheral nerve blocks.

Authors:  Doralina L Anghelescu; Brittney L Harris; Lane G Faughnan; Linda L Oakes; Kelley B Windsor; Becky B Wright; Jonathan A McCullers
Journal:  Paediatr Anaesth       Date:  2012-11       Impact factor: 2.556

6.  Use of a chlorhexidine-impregnated patch does not decrease the incidence of bacterial colonization of femoral nerve catheters: a randomized trial.

Authors:  Kristopher M Schroeder; Robert A Jacobs; Christopher Guite; Kyle Gassner; Brooke Anderson; Melanie J Donnelly
Journal:  Can J Anaesth       Date:  2012-08-02       Impact factor: 5.063

7.  The role of continuous peripheral nerve blocks.

Authors:  José Aguirre; Alicia Del Moral; Irina Cobo; Alain Borgeat; Stephan Blumenthal
Journal:  Anesthesiol Res Pract       Date:  2012-06-18

8.  Chlorhexidine gluconate dressings reduce bacterial colonization rates in epidural and peripheral regional catheters.

Authors:  Klaus Kerwat; Leopold Eberhart; Martina Kerwat; Dominik Hörth; Hinnerk Wulf; Thorsten Steinfeldt; Thomas Wiesmann
Journal:  Biomed Res Int       Date:  2015-03-23       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.